Tudor Investment Corp’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35M | Buy |
161,053
+47,510
| +42% | +$10.5M | 0.07% | 221 |
|
|
2025
Q4 | $25.9M | Buy |
+113,543
| New | +$25.9M | 0.05% | 327 |
|
|
2025
Q3 | – | Sell |
-330,873
| Closed | -$67.4M | – | 3294 |
|
|
2025
Q2 | $61.4M | Buy |
+330,873
| New | +$61.5M | 0.13% | 99 |
|
|
2024
Q1 | – | Sell |
-62,397
| Closed | -$10.8M | – | 2151 |
|
|
2023
Q4 | $9.67M | Buy |
62,397
+49,699
| +391% | +$7.25M | 0.08% | 354 |
|
|
2023
Q3 | $1.89M | Sell |
12,698
-144,587
| -92% | -$21.2M | 0.02% | 955 |
|
|
2023
Q2 | $21.2M | Buy |
+157,285
| New | +$23.1M | 0.25% | 49 |
|
|
2022
Q4 | – | Sell |
-10,591
| Closed | -$1.42M | – | 2305 |
|
|
2022
Q3 | $1.42M | Buy |
10,591
+2,124
| +25% | +$305K | 0.03% | 699 |
|
|
2022
Q2 | $1.3M | Buy |
+8,467
| New | +$1.29M | 0.03% | 730 |
|
|
2022
Q1 | – | Sell |
-39,268
| Closed | -$5.32M | – | 1917 |
|
|
2021
Q4 | $5.32M | Buy |
39,268
+23,690
| +152% | +$2.8M | 0.09% | 250 |
|
|
2021
Q3 | $1.68M | Sell |
15,578
-20,146
| -56% | -$2.3M | 0.03% | 826 |
|
|
2021
Q2 | $4.02M | Buy |
35,724
+18,770
| +111% | +$2.11M | 0.08% | 298 |
|
|
2021
Q1 | $1.83M | Buy |
+16,954
| New | +$1.81M | 0.04% | 557 |
|
|
2020
Q4 | – | Sell |
-48,175
| Closed | -$4.22M | – | 1301 |
|
|
2020
Q3 | $4.22M | Buy |
+48,175
| New | +$4.54M | 0.18% | 94 |
|
|
2020
Q2 | – | Sell |
-40,340
| Closed | -$3.07M | – | 1142 |
|
|
2020
Q1 | $3.07M | Sell |
40,340
-6,977
| -15% | -$594K | 0.28% | 42 |
|
|
2019
Q4 | $4.19M | Buy |
+47,317
| New | +$3.93M | 0.19% | 109 |
|
|
2019
Q2 | – | Sell |
-38,614
| Closed | -$3.11M | – | 1066 |
|
|
2019
Q1 | $3.11M | Buy |
+38,614
| New | +$3.16M | 0.13% | 174 |
|
|
2018
Q4 | – | Sell |
-125,972
| Closed | -$11.9M | – | 985 |
|
|
2018
Q3 | $11.9M | Sell |
125,972
-23,195
| -16% | -$2.2M | 0.3% | 32 |
|
|
2018
Q2 | $13.8M | Buy |
149,167
+63,113
| +73% | +$6.16M | 0.48% | 20 |
|
|
2018
Q1 | $8.14M | Buy |
+86,054
| New | +$9.45M | 0.26% | 34 |
|
|
2017
Q3 | – | Sell |
-15,220
| Closed | -$1.1M | – | 1060 |
|
|
2017
Q2 | $1.1M | Buy |
15,220
+3,058
| +25% | +$206K | 0.03% | 313 |
|
|
2017
Q1 | $792K | Buy |
12,162
+7,262
| +148% | +$457K | 0.02% | 484 |
|
|
2016
Q4 | $307K | Sell |
4,900
-4,000
| -45% | -$244K | 0.01% | 1011 |
|
|
2016
Q3 | $561K | Buy |
+8,900
| New | +$576K | 0.01% | 675 |
|
|
2016
Q2 | – | Sell |
-4,100
| Closed | -$234K | – | 1585 |
|
|
2016
Q1 | $234K | Sell |
4,100
-28,825
| -88% | -$1.61M | 0.01% | 1428 |
|
|
2015
Q4 | $1.95M | Sell |
32,925
-16,555
| -33% | -$954K | 0.05% | 221 |
|
|
2015
Q3 | $2.69M | Buy |
49,480
+42,980
| +661% | +$2.8M | 0.09% | 154 |
|
|
2015
Q2 | $437K | Sell |
6,500
-3,570
| -35% | -$233K | 0.01% | 854 |
|
|
2015
Q1 | $589K | Sell |
10,070
-2,844
| -22% | -$172K | 0.02% | 650 |
|
|
2014
Q4 | $845K | Sell |
12,914
-248,786
| -95% | -$15.7M | 0.03% | 426 |
|
|
2014
Q3 | $15.1M | Buy |
261,700
+4,356
| +2% | +$242K | 0.55% | 21 |
|
|
2014
Q2 | $14.5M | Buy |
+257,344
| New | +$13.5M | 0.56% | 33 |
|
|
2014
Q1 | – | Sell |
-76,100
| Closed | -$4.02M | – | 1174 |
|
|
2013
Q4 | $4.02M | Sell |
76,100
-277,000
| -78% | -$13.6M | 0.2% | 73 |
|
|
2013
Q3 | $15.8M | Buy |
353,100
+3,100
| +0.9% | +$137K | 0.65% | 20 |
|
|
2013
Q2 | $14.5M | Buy |
+350,000
| New | +$15.3M | 1.09% | 15 |
|
Other funds holding ABBV
VCM
VPM
Tudor Investment Corp's ABBV Position: Q1 2026 in Review
Tudor Investment Corp increased its AbbVie (ABBV) stake by 42% in Q1 2026, buying an estimated $10.5M and bringing the position to 161,053 shares worth $35M. The position accounts for 0.07% of the portfolio, ranked #221.
Tudor Investment Corp first reported a position in ABBV in Q2 2013 and has held it in 34 quarters since. The position peaked at $61.4M in Q2 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Tudor Investment Corp held 161,053 shares of AbbVie worth $35M as of Q1 2026.
- Tudor Investment Corp bought 47,510 AbbVie shares in Q1 2026, an estimated $10.5M.
- AbbVie made up 0.07% of Tudor Investment Corp's portfolio in Q1 2026, its #221 holding.
- Tudor Investment Corp first reported a position in AbbVie in Q2 2013 and has held it in 34 quarters since.
- Tudor Investment Corp's AbbVie position peaked at $61.4M in Q2 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.